Leslie, Kieron S <br/><br/>
An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa.  [electronic resource] 

 -  Journal of the American Academy of Dermatology  Feb 2014 
 - 243-51 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6787 
<br/><br/><label>Standard No.: </label>10.1016/j.jaad.2013.09.044  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Hidradenitis Suppurativa--diagnosis<br/>Humans<br/>Injections, Subcutaneous<br/>Interleukin 1 Receptor Antagonist Protein--administration & dosage<br/>Male<br/>Patient Satisfaction--statistics & numerical data<br/>Pilot Projects<br/>Prospective Studies<br/>Quality of Life<br/>Severity of Illness Index<br/>Treatment Outcome